Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased…

Overview of attention for article published in Frontiers in immunology, July 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 38,148 followers.

RT @FrontImmunol: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects… https://…

RT @FrontImmunol: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects… https://…

Depleting autologous NK cells may help engraftment & immune reconstitution in patients with RAG/NHEJ defects treated by HSCT. https://t.co/t1W6TNgTP7

RT @FrontImmunol: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects… https://…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.